Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Olfactory Transcranial Focused Ultrasound

NCT: NCT07658365 · NOT_YET_RECRUITING

NCT IDNCT07658365
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2028-04-30
SponsorMedical University of South Carolina (OTHER)
First posted
Last updated

Brief Summary

This study investigates the causal effects of low-intensity transcranial focused ultrasound (tFUS) on odor valence perception and odor-elicited avoidance behaviors in healthy adults. Participants undergo sham and active tFUS targeting the amygdala (AMYG) and ventral striatal olfactory tubercle (VSOT) in a within-subject, randomized, sham-controlled crossover design. Outcomes include subjective odor ratings and objective neurophysiological and behavioral indices of odor valence processing. This research is exploratory and mechanistic in nature and is not intended to evaluate clinical safety or therapeutic efficacy.

Frequently Asked Questions

What is Olfactory Transcranial Focused Ultrasound?

Olfactory Transcranial Focused Ultrasound is a clinical trial registered under NCT07658365. Current status: NOT_YET_RECRUITING.

What is the status of NCT07658365?

The current status of NCT07658365 (Olfactory Transcranial Focused Ultrasound) is: NOT_YET_RECRUITING.

When did Olfactory Transcranial Focused Ultrasound start?

Olfactory Transcranial Focused Ultrasound started on 2026-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.